Interesting stories emerge out of the university venturing world on a regular basis – be it the groundbreaking ability to edit genes, solar panels that boost efficiency by a third or a miraculous material that stops drugs from crystallising and makes them soluble.

Sometimes, the interesting story even includes a long-running legal battle – when it comes to the aforementioned gene-editing technology, known as Crispr-Cas9, for example, University of California Berkeley and Broad Institute have been fighting a drawn-out dispute…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?